No idea. But, given that STAM bought their first 6.5m OMN shares at an average of 1.41$ (which is above current liquidation value)... it would be a bit of a dumb move, wouldn’t it?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025